Evidence map›Paper›PMID 35877244›Full record

SynthesisCurrent oncology (Toronto, Ont.)2022

Surgical Management of Craniovertebral Junction Schwannomas: A Systematic Review.

Paolo Palmisciano, Gianluca Ferini, Gina Watanabe, Andie Conching, Christian Ogasawara, Gianluca Scalia, Othman Bin-Alamer, Ali S Haider, Maurizio Passanisi, Rosario Maugeri and 6 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Frontiers in medicine · 2024
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Paolo PalmiscianoDepartment of Neurosurgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.ORCID 0000-0003-0711-3975
Gianluca FeriniDepartment of Radiation Oncology, REM Radioterapia srl, 95029 Viagrande, Italy.ORCID 0000-0002-2305-5544
Gina WatanabeJohn A. Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, USA.
Andie ConchingJohn A. Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, USA.
Christian OgasawaraJohn A. Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, USA.
Gianluca ScaliaDepartment of Neurosurgery, Highly Specialized Hospital and of National Importance "Garibaldi", 95122 Catania, Italy.ORCID 0000-0002-9465-2506
Othman Bin-AlamerDepartment of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Ali S HaiderDepartment of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Maurizio PassanisiTrauma Center, Gamma Knife Center, Department of Neurosurgery, Cannizzaro Hospital, 95126 Catania, Italy.
Rosario MaugeriUnit of Neurosurgery, Department of Experimental Biomedicine & Clinical Neuroscience, Azienda Ospedaliera Universitaria Policlinico, 90127 Palermo, Italy.
Samer S HozDepartment of Neurological Surgery, Padilla Hospital, Tucumán T4000, Argentina.ORCID 0000-0003-4584-5931
Matias BaldonciniDepartment of Neurological Surgery, San Fernando Hospital, Buenos Aires B1646, Argentina.
Alvaro CamperoDepartment of Neurological Surgery, Padilla Hospital, Tucumán T4000, Argentina.
Maurizio SalvatiDepartment of Neurosurgery, Neuromed, IRCCS, Sapienza University of Rome, 86077 Pozzilli, Italy.
Aaron A Cohen-GadolDepartment of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Giuseppe E UmanaTrauma Center, Gamma Knife Center, Department of Neurosurgery, Cannizzaro Hospital, 95126 Catania, Italy.ORCID 0000-0002-1573-431X
University of Hawaiʻi at Mānoa · USNeurological Surgery · USOspedale Cannizzaro · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale Garibaldi · ITThe University of Texas MD Anderson Cancer Center · USUniversity of Cincinnati Medical Center · USUniversity of Pittsburgh Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCraniovertebral junction (CVJ) schwannomas are rare, with surgery and stereotactic radiosurgery (SRS) being effective yet challenging options. We systematically reviewed the literature on CVJ schwannomas.

methodsPubMed, Scopus, Web-of-Science, and Cochrane were searched following the PRISMA statement to include studies reporting CVJ schwannomas. Clinical features, management, and outcomes were analyzed.

resultsWe collected 353 patients from 101 included articles. Presenting symptoms were mostly neck pain (30.3%) and headache (26.3%), with most cranial neuropathies involving the XII (31.2%) and X (24.4%) nerves. Most tumors originated from C2 (30.9%) and XII (29.4%) nerves, being extracranial (45.1%) and intradural-extradural (44.2%). Erosion of C1-C2 vertebrae (37.1%), the hypoglossal canal (28.3%), and/or jugular foramen (20.1%) were noted. All tumors were operated, preferably with the retrosigmoid approach (36.5%), with the far-lateral approach (29.7%) or with the posterior approach and cervical laminectomy (26.9%), far-lateral approaches (14.2%), or suboccipital craniotomy with concurrent cervical laminectomy (14.2%). Complete tumor resection was obtained most frequently (61.5%). Adjuvant post-surgery stereotactic radiosurgery was delivered in 5.9% patients. Median follow-up was 27 months (range, 12-252). Symptom improvement was noted in 88.1% of cases, and cranial neuropathies showed improvement in 10.2%. Post-surgical complications occurred in 83 patients (23.5%), mostly dysphagia (7.4%), new cranial neuropathies (6.2%), and cerebrospinal fluid leak (5.9%). A total of 16 patients (4.5%) had tumor recurrence and 7 died (2%), with median overall survival of 2.7 months (range, 0.1-252).

conclusionsMicrosurgical resection is safe and effective for CVJ schwannomas. Data on SRS efficacy and indications are still lacking, and its role deserves further evaluation.

Indexed as

Cranial Nerve DiseasesNeurilemmomaRadiosurgeryHumansNeoplasm Recurrence, Localcranial nerve tumorcraniovertebral junctionneuro-oncologyperipheral nerve tumorschwannomaskull basespine

Identifiers

PMID35877244
PMCPMC9319499
OpenAlexW4285006753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.